432 related articles for article (PubMed ID: 17420279)
1. Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase.
Suzuki A; Okamoto S; Lee S; Saito K; Shiuchi T; Minokoshi Y
Mol Cell Biol; 2007 Jun; 27(12):4317-27. PubMed ID: 17420279
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.
Yoon MJ; Lee GY; Chung JJ; Ahn YH; Hong SH; Kim JB
Diabetes; 2006 Sep; 55(9):2562-70. PubMed ID: 16936205
[TBL] [Abstract][Full Text] [Related]
3. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase.
Minokoshi Y; Kim YB; Peroni OD; Fryer LG; Müller C; Carling D; Kahn BB
Nature; 2002 Jan; 415(6869):339-43. PubMed ID: 11797013
[TBL] [Abstract][Full Text] [Related]
4. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1.
Lee WJ; Kim M; Park HS; Kim HS; Jeon MJ; Oh KS; Koh EH; Won JC; Kim MS; Oh GT; Yoon M; Lee KU; Park JY
Biochem Biophys Res Commun; 2006 Feb; 340(1):291-5. PubMed ID: 16364253
[TBL] [Abstract][Full Text] [Related]
5. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle.
Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E599-607. PubMed ID: 15562249
[TBL] [Abstract][Full Text] [Related]
6. AMPK and ACC phosphorylation: effect of leptin, muscle fibre type and obesity.
Janovská A; Hatzinikolas G; Staikopoulos V; McInerney J; Mano M; Wittert GA
Mol Cell Endocrinol; 2008 Mar; 284(1-2):1-10. PubMed ID: 18255222
[TBL] [Abstract][Full Text] [Related]
7. AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment.
Steinberg GR; Rush JW; Dyck DJ
Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E648-54. PubMed ID: 12441311
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
Zhou W; Han WF; Landree LE; Thupari JN; Pinn ML; Bililign T; Kim EK; Vadlamudi A; Medghalchi SM; El Meskini R; Ronnett GV; Townsend CA; Kuhajda FP
Cancer Res; 2007 Apr; 67(7):2964-71. PubMed ID: 17409402
[TBL] [Abstract][Full Text] [Related]
9. Low-intensity contraction activates the alpha1-isoform of 5'-AMP-activated protein kinase in rat skeletal muscle.
Toyoda T; Tanaka S; Ebihara K; Masuzaki H; Hosoda K; Sato K; Fushiki T; Nakao K; Hayashi T
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E583-90. PubMed ID: 16249251
[TBL] [Abstract][Full Text] [Related]
10. Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase.
Du M; Shen QW; Zhu MJ; Ford SP
J Anim Sci; 2007 Apr; 85(4):919-27. PubMed ID: 17178807
[TBL] [Abstract][Full Text] [Related]
11. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor alpha and its response element are required but not sufficient for transcriptional activation of the mouse heart-type fatty acid binding protein gene.
Kawabe K; Saegusa H; Seto K; Urabe H; Motojima K
Int J Biochem Cell Biol; 2005 Jul; 37(7):1534-46. PubMed ID: 15833283
[TBL] [Abstract][Full Text] [Related]
13. Genistein stimulates fatty acid oxidation in a leptin receptor-independent manner through the JAK2-mediated phosphorylation and activation of AMPK in skeletal muscle.
Palacios-González B; Zarain-Herzberg A; Flores-Galicia I; Noriega LG; Alemán-Escondrillas G; Zariñan T; Ulloa-Aguirre A; Torres N; Tovar AR
Biochim Biophys Acta; 2014 Jan; 1841(1):132-40. PubMed ID: 24013029
[TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues.
LeBrasseur NK; Kelly M; Tsao TS; Farmer SR; Saha AK; Ruderman NB; Tomas E
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E175-81. PubMed ID: 16464908
[TBL] [Abstract][Full Text] [Related]
15. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes.
Finck BN; Bernal-Mizrachi C; Han DH; Coleman T; Sambandam N; LaRiviere LL; Holloszy JO; Semenkovich CF; Kelly DP
Cell Metab; 2005 Feb; 1(2):133-44. PubMed ID: 16054054
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts.
Fang X; Palanivel R; Zhou X; Liu Y; Xu A; Wang Y; Sweeney G
J Mol Endocrinol; 2005 Dec; 35(3):465-76. PubMed ID: 16326833
[TBL] [Abstract][Full Text] [Related]
17. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
18. Kinase-independent transcriptional co-activation of peroxisome proliferator-activated receptor alpha by AMP-activated protein kinase.
Bronner M; Hertz R; Bar-Tana J
Biochem J; 2004 Dec; 384(Pt 2):295-305. PubMed ID: 15312046
[TBL] [Abstract][Full Text] [Related]
19. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle.
Lee WJ; Song KH; Koh EH; Won JC; Kim HS; Park HS; Kim MS; Kim SW; Lee KU; Park JY
Biochem Biophys Res Commun; 2005 Jul; 332(3):885-91. PubMed ID: 15913551
[TBL] [Abstract][Full Text] [Related]
20. Metabolic adaptations to fasting and chronic caloric restriction in heart, muscle, and liver do not include changes in AMPK activity.
Gonzalez AA; Kumar R; Mulligan JD; Davis AJ; Weindruch R; Saupe KW
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E1032-7. PubMed ID: 15251868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]